IDXX - CONSENSUS CO - IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. (IDXX) possesses exceptional pricing power due to its razor-and-blade model of selling consumables for its analyzers, which is confirmed by the company's pricing chart, where the current metric stands at 714.96. The business relies on the synergy between veterinary medicine and IT, creating a stream of recurring payments for software and tests. Low staff turnover is ensured by the team's sincere commitment to the idea of protecting pet health.

The integration of AI diagnostics through clinic partnerships defines the growth potential of IDEXX Laboratories, Inc. (IDXX), which is reflected in the history of the consensus target price for the stock. This indicator represents the weighted average of target prices from leading analysts, measuring market expectations for the asset's fair value to assess the risks of capital freeze or an upcoming business revaluation.